Australia's Therapeutic Goods Administration (TGA) has recognized the two-dose course of the Russian Sputnik V vaccine against COVID-19 as an acceptable form of coronavirus vaccination for travellers.
"Today, the TGA determined that an additional COVID-19 vaccine, the two-dose course of the Gamaleya Institute vaccine (Sputnik V, Russian Federation) would be 'recognized' for the purpose of establishing a traveller's vaccination status," the TGA said in a Monday statement.
The regulator explained that additional data on the Russian vaccine's effectiveness showed that two doses of Sputnik V demonstrated an average efficacy against symptomatic COVID-19 infection of 89 percent and against hospitalization or death of 98-100 percent.
"The single-dose course of the Gamaleya vaccine ('Sputnik Light') is not currently recognized by the TGA," the Australian regulator specified. (ANI/Sputnik)
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor